WO2006026020A3 - Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin - Google Patents
Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin Download PDFInfo
- Publication number
- WO2006026020A3 WO2006026020A3 PCT/US2005/027183 US2005027183W WO2006026020A3 WO 2006026020 A3 WO2006026020 A3 WO 2006026020A3 US 2005027183 W US2005027183 W US 2005027183W WO 2006026020 A3 WO2006026020 A3 WO 2006026020A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- oncofetal fibronectin
- detection
- disease
- marker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Nanotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002575675A CA2575675A1 (en) | 2004-07-30 | 2005-07-29 | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
EP05810341A EP1778874B1 (en) | 2004-07-30 | 2005-07-29 | Oncofetal fibronectin as a marker for cervical cancer |
AT05810341T ATE534750T1 (en) | 2004-07-30 | 2005-07-29 | ONCOFETAL FIBRONECTIN AS A CERVICAL CARCINOMA MARKER |
AU2005280528A AU2005280528B2 (en) | 2004-07-30 | 2005-07-29 | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
JP2007523875A JP2008514900A (en) | 2004-07-30 | 2005-07-29 | Oncofetal fibronectin as a marker of disease and other conditions and methods for detection of oncofetal fibronectin |
HK07111819.9A HK1103527A1 (en) | 2004-07-30 | 2007-11-01 | Oncofetal fibronectin as a marker for cervical cancer |
AU2011201303A AU2011201303B2 (en) | 2004-07-30 | 2011-03-22 | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59282504P | 2004-07-30 | 2004-07-30 | |
US59280404P | 2004-07-30 | 2004-07-30 | |
US59282404P | 2004-07-30 | 2004-07-30 | |
US59280304P | 2004-07-30 | 2004-07-30 | |
US59282304P | 2004-07-30 | 2004-07-30 | |
US60/592,825 | 2004-07-30 | ||
US60/592,823 | 2004-07-30 | ||
US60/592,824 | 2004-07-30 | ||
US60/592,803 | 2004-07-30 | ||
US60/592,804 | 2004-07-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006026020A2 WO2006026020A2 (en) | 2006-03-09 |
WO2006026020A9 WO2006026020A9 (en) | 2006-07-06 |
WO2006026020A3 true WO2006026020A3 (en) | 2007-08-16 |
Family
ID=35841972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/027183 WO2006026020A2 (en) | 2004-07-30 | 2005-07-29 | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
Country Status (10)
Country | Link |
---|---|
US (8) | US20060024724A1 (en) |
EP (2) | EP1778874B1 (en) |
JP (2) | JP2008514900A (en) |
AT (1) | ATE534750T1 (en) |
AU (2) | AU2005280528B2 (en) |
CA (1) | CA2575675A1 (en) |
DK (1) | DK2299275T3 (en) |
HK (1) | HK1103527A1 (en) |
NZ (1) | NZ582466A (en) |
WO (1) | WO2006026020A2 (en) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
CA2575675A1 (en) | 2004-07-30 | 2006-03-09 | Adeza Biomedical Corporation | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
JP4306607B2 (en) * | 2004-12-24 | 2009-08-05 | 富士ゼロックス株式会社 | Field effect transistor |
US20060239398A1 (en) * | 2005-03-07 | 2006-10-26 | Fused Multimodality Imaging, Ltd. | Breast diagnostic apparatus for fused SPECT, PET, x-ray CT, and optical surface imaging of breast cancer |
ES2291071B1 (en) * | 2005-06-13 | 2009-03-16 | Proyecto De Biomedicina Cima, S.L. | AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTINE. |
US20070015166A1 (en) * | 2005-07-14 | 2007-01-18 | Nilsen Thor W | Lateral flow methods and devices for detection of nucleic acid binding proteins |
WO2007127392A2 (en) * | 2006-04-27 | 2007-11-08 | Pronovost Allan D | Devices and methods for collecting oral samples of enriched serous fluid |
US20080108097A1 (en) * | 2006-07-24 | 2008-05-08 | National Institute Of Advanced Industrial Science And Technology | Method for producing complex of biotin-labeled cypridina (cypridina noctiluca) luciferase with streptoavidin and method for stabilizing the same |
BRPI0717416A2 (en) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | METHOD FOR PERFORMING A HIGH PRODUCTIVITY COMPLEX IMMUNOASON, AND |
WO2008046510A1 (en) * | 2006-10-16 | 2008-04-24 | Bayer Healthcare Ag | Fn1 as a biomarker, therapeutic and diagnostic target |
EP2118666B1 (en) * | 2007-03-07 | 2011-08-03 | Mosaiques Diagnostics And Therapeutics AG | Method for the standardization of the concentration of analytes in a urine sample |
EP1972940A1 (en) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Method and marker for diagnosing kidney disease |
US20080241865A1 (en) * | 2007-03-26 | 2008-10-02 | National Institute Of Advanced Industrial Science And Technology | Visible to near-infrared light probe comprising complex of cypridina luciferase and quantum dot |
MX2009010639A (en) * | 2007-04-02 | 2009-10-23 | Philogen Spa | The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases. |
EP2179291B1 (en) * | 2007-07-13 | 2014-10-22 | Nestec S.A. | Drug selection for lung cancer therapy using antibody-based arrays |
US8067730B2 (en) | 2007-07-20 | 2011-11-29 | The George Washington University | Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry |
US7964843B2 (en) | 2008-07-18 | 2011-06-21 | The George Washington University | Three-dimensional molecular imaging by infrared laser ablation electrospray ionization mass spectrometry |
US8901487B2 (en) | 2007-07-20 | 2014-12-02 | George Washington University | Subcellular analysis by laser ablation electrospray ionization mass spectrometry |
CN103212072B (en) * | 2007-07-25 | 2015-07-22 | 菲洛根股份公司 | An antigen associated with lung cancers and lymphomas |
US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
WO2009047280A2 (en) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptide marker for the diagnosis of prostate cancer |
EP2051078A1 (en) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Method and marker for diagnosing diabetes mellitus |
AU2014274545B2 (en) * | 2007-10-30 | 2016-10-13 | Philogen S.P.A | An antigen associated with rheumatoid arthritis |
SI2209805T1 (en) * | 2007-10-30 | 2017-11-30 | Philogen S.P.A. | An antigen associated with rheumatoid arthritis |
MX340916B (en) | 2008-01-18 | 2016-07-29 | President And Fellows Of Harvard College * | Methods of detecting signatures of disease or conditions in bodily fluids. |
ES2398618T3 (en) | 2008-02-25 | 2013-03-20 | Nestec S.A. | Drug selection for breast cancer therapy using antibody matrices |
JP2011515672A (en) * | 2008-03-19 | 2011-05-19 | モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー | Methods and markers for diagnosis of renal tubular injury and disease |
EP2271930A4 (en) * | 2008-04-18 | 2011-04-27 | Univ Utah Res Found | Use of a steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment |
JP5084597B2 (en) * | 2008-04-24 | 2012-11-28 | キヤノン株式会社 | Mass spectrometry substrate and mass spectrometry method |
WO2010031822A1 (en) * | 2008-09-17 | 2010-03-25 | Mosaiques Diagnostics And Therapeutics Ag | Kidney cell carcinoma |
DE102008053503B4 (en) * | 2008-10-28 | 2011-04-28 | Justus-Liebig-Universität Giessen | Immunological test for the detection of autoantibodies against testicular antigens |
CA2747154C (en) * | 2008-12-19 | 2015-11-10 | Philogen S.P.A. | Immunocytokines for tumour therapy with chemotherapeutic agents |
CA2748401C (en) * | 2009-01-07 | 2017-09-12 | Philogen S.P.A. | Antigens associated with endometriosis |
WO2010104646A1 (en) * | 2009-03-09 | 2010-09-16 | Scott and White Memorial Hospital | Method of testing a patient for hypertension and related method of treatment and test kit |
GB0906643D0 (en) * | 2009-04-17 | 2009-06-03 | Wilson Stuart M | Detection of bacteria and fungi |
JP5795311B2 (en) | 2009-07-15 | 2015-10-14 | ネステク ソシエテ アノニム | Drug selection for gastric cancer therapy using antibody-based arrays |
EP2947096B1 (en) | 2009-08-05 | 2018-11-28 | Philogen S.p.A. | Targeting of bone marrow neovasculature |
JP5828195B2 (en) * | 2010-03-11 | 2015-12-02 | ユニバーシティ オブ ルイスビル リサーチ ファンデーション,インコーポレイテッドUniversity Of Louisville Research Foundation,Inc. | Methods for predicting pregnancy loss risk and methods for reducing pregnancy loss risk |
CN102309809B (en) * | 2010-07-09 | 2013-11-20 | 同济大学 | Neostomy system |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
KR20130041961A (en) | 2010-07-23 | 2013-04-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Methods for detecting signatures of disease or conditions in bodily fluids |
BR112013001752A2 (en) | 2010-07-23 | 2016-05-31 | Harvard College | method of detecting disease or condition using phagocytic cells |
EP2596116A4 (en) | 2010-07-23 | 2014-03-19 | Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
AU2011308615B2 (en) * | 2010-10-01 | 2015-02-05 | Hologic, Inc. | Immunoassay test strip for use in a diagnostic system |
US9271991B2 (en) | 2010-10-27 | 2016-03-01 | Dignity Health | Trimegestone (TMG) for treatment of preterm birth |
WO2012075318A2 (en) * | 2010-12-01 | 2012-06-07 | Cell Signaling Technology, Inc. | Fn1 and alk gene translocations in cancer and alk kinase expression in ovarian cancer |
JP5947533B2 (en) * | 2011-01-19 | 2016-07-06 | キヤノン株式会社 | Information acquisition method |
US9719995B2 (en) | 2011-02-03 | 2017-08-01 | Pierian Holdings, Inc. | Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling |
FR2976587B1 (en) * | 2011-06-20 | 2015-04-03 | Basf Beauty Care Solutions F | IN VITRO DOSING METHOD BY IMMUNOLOGICAL TECHNIQUE |
KR101188355B1 (en) | 2011-06-24 | 2012-10-08 | 광주과학기술원 | Separating method of microscopic parts using albumin solution |
IL214096A (en) * | 2011-07-14 | 2016-02-29 | Gideon Mor | System for detection of meconium in amniotic fluid |
EP2732457A4 (en) | 2011-07-14 | 2015-09-16 | Univ George Washington | Plume collimation for laser ablation electrospray ionization mass spectrometry |
WO2013027611A1 (en) * | 2011-08-24 | 2013-02-28 | 栄研化学株式会社 | Leukocyte measurement device and reagent kit |
EP2751562B1 (en) | 2011-09-02 | 2015-09-16 | Nestec S.A. | Profiling of signal pathway proteins to determine therapeutic efficacy |
EP2836845B1 (en) * | 2012-04-13 | 2018-05-09 | DiabetOmics, Inc. | Maternal biomarkers for gestational diabetes |
JP2015522260A (en) | 2012-06-15 | 2015-08-06 | ハリー スティリ, | Method for detecting a disease or condition |
JP5562508B1 (en) * | 2012-09-28 | 2014-07-30 | 積水メディカル株式会社 | Additives for measuring diluted samples in undiluted immunochromatographic reagents |
HUE044927T2 (en) | 2012-10-03 | 2019-11-28 | Philogen Spa | Antibody conjugate for use in treating inflammatory bowel disease |
DK2909315T3 (en) | 2012-10-19 | 2019-06-03 | Univ Wayne State | IDENTIFICATION AND ANALYSIS OF FEED TROPHY LOAD CELLS IN CERVIX SLIM FOR PRINATIC DIAGNOSIS |
WO2014066568A1 (en) | 2012-10-24 | 2014-05-01 | Winthrop-University Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
US20140227690A1 (en) * | 2013-02-08 | 2014-08-14 | St. John Heallth | Methods and compositions for assessment of fetal lung maturity |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
WO2014164366A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting cancer |
CN105229468A (en) * | 2013-06-04 | 2016-01-06 | 普默特株式社 | Have variable control line for the band that detects fast and the diagnostic kit using this band |
JP6698529B2 (en) * | 2013-12-12 | 2020-05-27 | ユーエムセー・ユトレヒト・ホールディング・ベー・フェー | Immunoglobulin-like molecule for fibronectin-EDA |
CN103743911B (en) * | 2013-12-31 | 2016-01-20 | 浙江爱康生物科技有限公司 | A kind of fibronectin determination kit and preparation method thereof |
EP2955517A1 (en) * | 2014-06-10 | 2015-12-16 | Siemens Healthcare Diagnostics Products GmbH | Process for the stabilisation of body fluid samples by the addition of detergent |
US20160025737A1 (en) | 2014-07-25 | 2016-01-28 | Diabetomics, Llc | Biomarkers for assessment of preeclampsia |
EP3677285B1 (en) | 2014-08-04 | 2023-12-13 | Case Western Reserve University | Targeting peptides for detecting prostate cancer |
US10925980B2 (en) | 2014-08-04 | 2021-02-23 | Case Western Reserve University | Molecular probes and methods of use |
CA2956723C (en) | 2014-08-12 | 2023-04-11 | Nextgen Jane, Inc. | System and method for monitoring health based on collected bodily fluid |
EP4075139A1 (en) | 2014-09-11 | 2022-10-19 | Harry Stylli | Methods of detecting prostate cancer |
CA2963968C (en) * | 2014-10-10 | 2024-01-09 | Wayne State University | Methods and compositions relating to assays of fetal extravillous trophoblast cells |
CN104965014B (en) * | 2015-07-06 | 2017-06-23 | 济南大学 | The preparation method of the compound carbon paste electrode of quantum dot/enzyme for detecting SAM |
WO2017084017A1 (en) * | 2015-11-16 | 2017-05-26 | 合肥立方制药股份有限公司 | Use of ed-b protein in diagnosis of tissue hyperplasia |
EP3387430A4 (en) * | 2015-12-11 | 2019-08-14 | Expression Pathology, Inc. | Srm/mrm assays |
WO2017106769A1 (en) * | 2015-12-17 | 2017-06-22 | Polymer Technology Systems, Inc. | Systems and methods for point-of-care hdl and ldl particle assay |
EP3422004B1 (en) * | 2016-02-24 | 2020-09-09 | Sekisui Medical Co., Ltd. | Method for detecting carcinoembryonic fibronectin using immunochromatography |
JP6168580B1 (en) * | 2016-02-24 | 2017-07-26 | 積水メディカル株式会社 | Detection method of oncofetal fibronectin using immunochromatography |
US20190094215A1 (en) * | 2016-03-31 | 2019-03-28 | Sekisui Medical Co., Ltd. | Oncofetal fibronectin detection method using simple immunoassay |
AU2017246480B2 (en) | 2016-04-06 | 2023-06-01 | Wayne State University | Isolation and analysis of fetal DNA from extravillous trophoblast cells retrieved from the endocervical canal |
WO2017180909A1 (en) | 2016-04-13 | 2017-10-19 | Nextgen Jane, Inc. | Sample collection and preservation devices, systems and methods |
US10191046B2 (en) * | 2016-05-23 | 2019-01-29 | Se-Hwan Paek | Immunobiosensor and sensor system including the same |
GB2552195A (en) * | 2016-07-13 | 2018-01-17 | Univ Oxford Innovation Ltd | Interferometric scattering microscopy |
CN107330263B (en) * | 2017-06-26 | 2020-07-28 | 成都知识视觉科技有限公司 | Computer-assisted breast invasive ductal carcinoma histological grading method |
SG11202002065VA (en) | 2017-09-13 | 2020-04-29 | Progenity Inc | Preeclampsia biomarkers and related systems and methods |
US20200230388A1 (en) * | 2017-09-18 | 2020-07-23 | North Carolina State University | Nanocellulose and nanocellulose composite arrays and devices and methods of making and using the same |
WO2019118420A1 (en) * | 2017-12-11 | 2019-06-20 | Stc. Unm | Mild traumatic brain injury diagnostic immunochromatographic microneedle patch |
WO2020081956A1 (en) * | 2018-10-18 | 2020-04-23 | Medimmune, Llc | Methods for determining treatment for cancer patients |
US20210405048A1 (en) * | 2018-11-08 | 2021-12-30 | Rochester Institute Of Technology | Diagnosing Sepsis or Bacteremia by Detecting Peptidoglycan Associated Lipoprotein (PAL) in Urine |
CN111235270B (en) * | 2019-08-29 | 2022-04-29 | 北京臻知医学科技有限责任公司 | Tumor antigen expression detection primer and kit based on high-throughput sequencing method |
EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | Assessment of preeclampsia using assays for free and dissociated placental growth factor |
CN111751356B (en) * | 2020-07-22 | 2022-05-24 | 攀钢集团研究院有限公司 | Method for simultaneously determining concentration components of divalent and trivalent iron ions in Fe-EDTA (ethylene diamine tetraacetic acid) complex denitration solution |
CN111751357B (en) * | 2020-07-22 | 2022-05-24 | 攀钢集团研究院有限公司 | Determination of Fe in a polymorphic iron ion coexisting system in EDTA (ethylene diamine tetraacetic acid) complex denitration liquid2+With Fe3+Method of content |
CN111751355B (en) * | 2020-07-22 | 2022-05-24 | 攀钢集团研究院有限公司 | Method for determining content of ferrous iron ions in Fe (II) -EDTA (ethylene diamine tetraacetic acid) complex denitration liquid |
WO2023032925A1 (en) * | 2021-08-30 | 2023-03-09 | 国立大学法人京都大学 | Testing method and testing reagent |
WO2023172575A2 (en) * | 2022-03-08 | 2023-09-14 | Aeena Dx, Inc. | Methods for disease detection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010585A1 (en) * | 1990-12-14 | 1992-06-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal restricted antigens |
US5693479A (en) * | 1993-03-10 | 1997-12-02 | The Trustees Of The University Of Pennsylvania | Fertility determination with transforming growth factor β |
WO2002101075A2 (en) * | 2001-06-13 | 2002-12-19 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
US20030049658A1 (en) * | 1999-12-10 | 2003-03-13 | David Smart | Assay |
EP1293926A2 (en) * | 1998-02-03 | 2003-03-19 | Adeza Biomedical Corporation | Start control method in a computer system |
WO2003036300A2 (en) * | 2001-10-26 | 2003-05-01 | University College London | Diagnosis of cervical cancer |
Family Cites Families (197)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US477718A (en) * | 1892-06-28 | Elevated track or tramway | ||
US522344A (en) * | 1894-07-03 | John f | ||
US477128A (en) * | 1892-06-14 | lantz | ||
US5622871A (en) | 1987-04-27 | 1997-04-22 | Unilever Patent Holdings B.V. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
US1947171A (en) | 1931-05-01 | 1934-02-13 | Prussing Walter | Tube making, capping, printing and enameling machine |
US4663290A (en) * | 1982-01-21 | 1987-05-05 | Molecular Genetics, Inc. | Production of reverse transcriptase |
US5073484A (en) | 1982-03-09 | 1991-12-17 | Bio-Metric Systems, Inc. | Quantitative analysis apparatus and method |
US4628027A (en) * | 1982-05-19 | 1986-12-09 | Molecular Engineering Associates, Ltd. | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
US4759376A (en) * | 1984-05-29 | 1988-07-26 | Nils Stormby | Endocervical sampling brush and smear method |
DK8601218A (en) * | 1984-07-18 | 1986-03-17 | ||
FR2570703B1 (en) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | RARE EARTH MACROPOLYCYCLIC COMPLEXES AND APPLICATION AS FLUORESCENT MARKERS |
US4960467A (en) * | 1985-02-11 | 1990-10-02 | The United States Of America As Represented By The Secretary Of The Army | Dermal substance collection device |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US5279943A (en) | 1985-08-02 | 1994-01-18 | Compagnie Oris Industrie | Homogeneous process for the detection and/or determination by luminescence of an analyte in a medium in which it may be present |
TW203120B (en) * | 1985-10-04 | 1993-04-01 | Abbott Lab | |
NL8503596A (en) | 1985-12-31 | 1987-07-16 | Futura Nova Bv | Apparatus for making a smear from a body cavity. |
US5243029A (en) * | 1986-04-09 | 1993-09-07 | Fred Hutchinson Cancer Research Center | Oncofetal structure of fibronectin |
US4894326A (en) * | 1986-04-09 | 1990-01-16 | Fred Hutchinson Cancer Research Center | Monoclonal antibody defining oncofetal structure of fibronectin |
US4777128A (en) | 1986-05-27 | 1988-10-11 | Ethigen Corporation | Fluorescence immunoassay involving energy transfer between two fluorophores |
US5466591A (en) | 1986-08-22 | 1995-11-14 | Hoffmann-La Roche Inc. | 5' to 3' exonuclease mutations of thermostable DNA polymerases |
US5455170A (en) * | 1986-08-22 | 1995-10-03 | Hoffmann-La Roche Inc. | Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05 |
US4889818A (en) | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
US5374553A (en) * | 1986-08-22 | 1994-12-20 | Hoffmann-La Roche Inc. | DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima |
US4960691A (en) * | 1986-09-29 | 1990-10-02 | Abbott Laboratories | Chromatographic test strip for determining ligands or receptors |
US5132097A (en) * | 1987-02-11 | 1992-07-21 | G.D. Research | Apparatus for analysis of specific binding complexes |
US4762133A (en) | 1987-03-20 | 1988-08-09 | Medical Dynamics, Inc. | Cervical cytology device |
CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
JPS63163167U (en) | 1987-04-15 | 1988-10-25 | ||
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
US4956302A (en) | 1987-09-11 | 1990-09-11 | Abbott Laboratories | Lateral flow chromatographic binding assay device |
US5185270A (en) * | 1987-11-17 | 1993-02-09 | Adeza Biomedical Corporation | Fetal fibronectin pregnancy test |
US5223440A (en) | 1987-11-17 | 1993-06-29 | Adeza Biomedical Corporation | Ex vivo product of conception test to determine abortion |
CA1337394C (en) | 1987-11-17 | 1995-10-24 | Nelson N. H. Teng | Vaginal sample test and reagents |
US5096830A (en) * | 1987-11-17 | 1992-03-17 | Adeza Biomedical Corporation | Preterm labor and membrane rupture test |
DE3741201A1 (en) | 1987-12-02 | 1989-06-15 | Schering Ag | ULTRASONIC PROCESS AND METHOD FOR IMPLEMENTING IT |
US5162508A (en) | 1987-12-18 | 1992-11-10 | Compagnie Oris Industrie | Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers |
US5209904A (en) | 1987-12-23 | 1993-05-11 | Abbott Laboratories | Agglutination reaction device utilizing selectively impregnated porous material |
US5244797B1 (en) | 1988-01-13 | 1998-08-25 | Life Technologies Inc | Cloned genes encoding reverse transcriptase lacking rnase h activity |
JP2907342B2 (en) | 1988-01-29 | 1999-06-21 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | Ion infiltration non-invasive sampling or delivery device |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
US20030232010A2 (en) * | 1988-03-29 | 2003-12-18 | Immunomedics, Inc. | Improved cytotoxic therapy |
SE463188B (en) | 1988-05-10 | 1990-10-22 | Stormby Nils | BRUSH FOR MEDICAL SAMPLING |
US5438984A (en) * | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US5079171A (en) * | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
US4919889A (en) | 1988-09-15 | 1990-04-24 | Aspen Diagnostics Corporation | Sample collection and transport fluid composition |
US5252459A (en) | 1988-09-23 | 1993-10-12 | Abbott Laboratories | Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles |
US5236846A (en) * | 1988-11-18 | 1993-08-17 | Adeza Biomedical Corporation | Ectopic pregnancy test |
US5512657A (en) | 1988-12-12 | 1996-04-30 | Bainbridge Sciences, Inc. | Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
US5108898A (en) * | 1989-01-18 | 1992-04-28 | Peters John H | Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy |
US5139023A (en) | 1989-06-02 | 1992-08-18 | Theratech Inc. | Apparatus and method for noninvasive blood glucose monitoring |
GB2236186B (en) * | 1989-08-22 | 1994-01-05 | Finnigan Mat Gmbh | Process and device for laser desorption of analyte molecular ions, especially of biomolecules |
US6146657A (en) | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US6713610B1 (en) * | 1990-01-12 | 2004-03-30 | Raju Kucherlapati | Human antibodies derived from immunized xenomice |
US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
AU7674591A (en) | 1990-04-12 | 1991-11-11 | Adeza Biomedical Corporation | Pregnancy induced hypertension and eclampsia immunoassay and reagents |
SE9001679L (en) | 1990-05-10 | 1991-09-16 | Medscand Ab | INSTRUMENTS FOR ENDO- AND ECTOCERVIC SAMPLING |
US5420176A (en) * | 1990-06-01 | 1995-05-30 | Imarx Pharmaceutical Corp. | Contrast media for ultrasonic imaging |
FR2664699B1 (en) | 1990-07-13 | 1995-08-18 | Cis Bio Int | METHOD FOR AMPLIFYING THE EMISSION SIGNAL OF A LUMINESCENT COMPOUND. |
JP2709311B2 (en) | 1990-09-28 | 1998-02-04 | エフ.ホフマン−ラ ロシュ アクチェンゲゼルシャフト | 5 → 3 ′ exonuclease mutation of thermostable DNA polymerase |
FI86777C (en) | 1990-12-31 | 1992-10-12 | Medix Biochemica Ab Oy | FOERFARANDE FOER DIAGNOSTICERING AV BRISTNINGEN AV FOSTERHINNORNA SAMT REAGENSFOERPACKNING FOER ANVAENDNING DAERVID |
US5198340A (en) * | 1991-01-17 | 1993-03-30 | Genentech, Inc. | Assay for free igf-i, igf-ii, and gh levels in body fluids |
US5211952A (en) | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
FI93607C (en) | 1991-05-24 | 1995-05-10 | John Koivukangas | Cutting Remedy |
EP0642667B1 (en) | 1991-11-04 | 2001-01-10 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
WO1993009432A1 (en) * | 1991-11-04 | 1993-05-13 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
US5516702A (en) * | 1991-11-06 | 1996-05-14 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
US5270166A (en) | 1992-03-30 | 1993-12-14 | Abbott Laboratories | Immunoassays employing generic anti-hapten antibodies and materials for use therein |
WO1993024836A1 (en) | 1992-05-29 | 1993-12-09 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
WO1993024838A1 (en) | 1992-05-29 | 1993-12-09 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
FI94181C (en) | 1992-06-29 | 1995-07-25 | Medix Biochemica Ab Oy | Diagnostic method for predicting the time of delivery and reagent kit used for it |
EP0663071B1 (en) * | 1992-09-28 | 2003-12-03 | Biex, Inc. | Method for prediction of premature labor |
US5491130A (en) | 1992-11-10 | 1996-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide inhibitors of fibronectin and related collagen-binding proteins |
CA2152676A1 (en) | 1993-01-22 | 1994-08-04 | John C. Leavitt | Assay method to rule out rupture of membranes in women at risk for imminent delivery |
US5876978A (en) * | 1993-04-06 | 1999-03-02 | Medical College Of Ohio | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
US5500375A (en) | 1993-04-13 | 1996-03-19 | Serex, Inc. | Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats |
US5645537A (en) * | 1993-04-20 | 1997-07-08 | Advanced Cytometrix, Inc. | Aspiration needle and syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology, and method |
PT700521E (en) * | 1993-05-28 | 2003-10-31 | Baylor College Medicine | METHOD AND MASS SPECTROMETER FOR DESSORING AND IONIZATION OF ANALYZES |
GB9315847D0 (en) * | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
US6251100B1 (en) | 1993-09-24 | 2001-06-26 | Transmedica International, Inc. | Laser assisted topical anesthetic permeation |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5370135A (en) * | 1993-10-13 | 1994-12-06 | Biex, Inc. | Use of estriol measurement to monitor tocolytic therapy |
US5650394A (en) * | 1993-11-04 | 1997-07-22 | Adeza Biomedical | Use of urinastatin-like compounds to prevent premature delivery |
ZA95960B (en) * | 1994-03-14 | 1995-10-10 | Genetics Inst | Use of interleukin-12 antagonists in the treatment of autoimmune diseases |
US6017693A (en) * | 1994-03-14 | 2000-01-25 | University Of Washington | Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry |
US5523229A (en) | 1994-03-22 | 1996-06-04 | Trustees Of The University Of Pennsylvania | Antibodies specific for oncofetal fibronectin |
US5597700A (en) | 1994-04-28 | 1997-01-28 | California Research, Llc | Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method |
US5658801A (en) | 1994-05-03 | 1997-08-19 | Spectral Diagnostics Inc. | Medical test kit |
US5771890A (en) | 1994-06-24 | 1998-06-30 | Cygnus, Inc. | Device and method for sampling of substances using alternating polarity |
US5586981A (en) | 1994-08-25 | 1996-12-24 | Xin-Hua Hu | Treatment of cutaneous vascular and pigmented lesions |
US5548158A (en) | 1994-09-02 | 1996-08-20 | National Semiconductor Corporation | Structure of bipolar transistors with improved output current-voltage characteristics |
US5912155A (en) | 1994-09-30 | 1999-06-15 | Life Technologies, Inc. | Cloned DNA polymerases from Thermotoga neapolitana |
US6015668A (en) * | 1994-09-30 | 2000-01-18 | Life Technologies, Inc. | Cloned DNA polymerases from thermotoga and mutants thereof |
US5691151A (en) | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
US5804452A (en) | 1995-04-27 | 1998-09-08 | Quidel Corporation | One step urine creatinine assays |
US20020164818A1 (en) | 1995-05-23 | 2002-11-07 | Gruber Karl F. | Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids |
US20030027216A1 (en) * | 2001-07-02 | 2003-02-06 | Kiernan Urban A. | Analysis of proteins from biological fluids using mass spectrometric immunoassay |
WO1996037777A1 (en) * | 1995-05-23 | 1996-11-28 | Nelson Randall W | Mass spectrometric immunoassay |
US6316266B1 (en) * | 1995-06-07 | 2001-11-13 | Arizona State University Board Of Regents | Sample presentation apparatus for mass spectrometry |
US6093541A (en) | 1995-06-07 | 2000-07-25 | Arizona State University Board Of Regents | Mass spectrometer having a derivatized sample presentation apparatus |
US6004770A (en) | 1995-06-07 | 1999-12-21 | Arizona State University Board Of Regents | Sample presentation apparatus for mass spectrometry |
US5656502A (en) | 1995-06-07 | 1997-08-12 | Diagnostic Chemicals Limited | Test strip holder and method of use |
US6632976B1 (en) | 1995-08-29 | 2003-10-14 | Kirin Beer Kabushiki Kaisha | Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene |
US5879367A (en) | 1995-09-08 | 1999-03-09 | Integ, Inc. | Enhanced interstitial fluid collection |
WO1997009451A1 (en) | 1995-09-08 | 1997-03-13 | Life Technologies, Inc. | Cloned dna polymerases from thermotoga and mutants thereof |
GB9518429D0 (en) | 1995-09-08 | 1995-11-08 | Pharmacia Biosensor | A rapid method for providing kinetic and structural data in molecular interaction analysis |
US6624882B2 (en) | 1995-09-08 | 2003-09-23 | Integ, Inc. | Methods of sampling body fluid |
US5989409A (en) | 1995-09-11 | 1999-11-23 | Cygnus, Inc. | Method for glucose sensing |
CA2243989A1 (en) | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for detecting binding of ligand pair using non-fluorescent label |
US6678669B2 (en) | 1996-02-09 | 2004-01-13 | Adeza Biomedical Corporation | Method for selecting medical and biochemical diagnostic tests using neural network-related applications |
EP0889326B1 (en) * | 1996-03-08 | 2002-11-13 | Universidad de las Islas Baleares | Process for evaluating the global capacity of urine to form calcic renal calculus, and corresponding kit |
US5808300A (en) | 1996-05-10 | 1998-09-15 | Board Of Regents, The University Of Texas System | Method and apparatus for imaging biological samples with MALDI MS |
US6005113A (en) | 1996-05-15 | 1999-12-21 | Molecular Probes, Inc. | Long wavelength dyes for infrared tracing |
GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
US6449562B1 (en) * | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
DE69735445T2 (en) | 1996-12-10 | 2006-08-10 | Sequenom, Inc., San Diego | NON-VOLATILE, NON-VOLATILE MOLECULES FOR MASS MARKING |
DE69838519T2 (en) | 1997-01-15 | 2008-07-03 | Xzillion Gmbh & Co. Kg | Mass-labeled hybridization probes |
US6017703A (en) * | 1997-03-06 | 2000-01-25 | Bard Diagnostic Sciences, Inc. | Methods and compositions for screening for or modulating a tumor associated antigen |
ES2355739T3 (en) | 1997-04-03 | 2011-03-30 | Life Technologies Corporation | COMPOSITIONS AND METHODS FOR CHAIN REACTION OF THE INVERSE TRANSCRIPTASE POLYMERASE (RT-PCR). |
AU7023798A (en) * | 1997-04-30 | 1998-11-24 | De Novo Enzyme Corporation | Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
US6156546A (en) | 1997-05-16 | 2000-12-05 | Washington State University Research Foundation | Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter coli and Campylobacter jejuni |
NZ516848A (en) * | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
US5964735A (en) | 1997-07-01 | 1999-10-12 | Medisys Technologies, Inc. | Fine needle aspiration safety syringe |
US5897840A (en) | 1997-07-16 | 1999-04-27 | Battelle Memorial Institute | Multi-chambered urine specimen container for automatic extraction and high forensic integrity |
US6436721B1 (en) | 1997-07-25 | 2002-08-20 | Bayer Corporation | Device and method for obtaining clinically significant analyte ratios |
US6503198B1 (en) * | 1997-09-11 | 2003-01-07 | Jack L. Aronowtiz | Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods |
US6168779B1 (en) * | 1997-09-16 | 2001-01-02 | The Regents Of The University Of California | Methods and kits for identifying ductal orifices |
US6221622B1 (en) * | 1998-04-28 | 2001-04-24 | The Regents Of The University Of California | Method and kit for obtaining fluids and cellular material from breast ducts |
DE19754978C2 (en) | 1997-12-11 | 2000-07-13 | Bruker Daltonik Gmbh | Sample holder for MALDI mass spectrometry along with the process for producing the plates and applying the samples |
US6844158B1 (en) | 1997-12-22 | 2005-01-18 | Hitachi Chemical Co., Ltd. | Direct RT-PCR on oligonucleotide-immobilized PCR microplates |
US6190315B1 (en) | 1998-01-08 | 2001-02-20 | Sontra Medical, Inc. | Sonophoretic enhanced transdermal transport |
US6265715B1 (en) | 1998-02-02 | 2001-07-24 | Helene Perreault | Non-porous membrane for MALDI-TOFMS |
US6267722B1 (en) * | 1998-02-03 | 2001-07-31 | Adeza Biomedical Corporation | Point of care diagnostic systems |
US6173202B1 (en) | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
US6368873B1 (en) | 1998-04-09 | 2002-04-09 | Applied Biotech, Inc. | Identification of human urine for drug testing |
US6723564B2 (en) * | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
US20030045681A1 (en) | 1998-05-11 | 2003-03-06 | Anthony J. Zelano | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
US20030176663A1 (en) | 1998-05-11 | 2003-09-18 | Eidgenossische Technische Hochscule | Specific binding molecules for scintigraphy |
US6492180B2 (en) | 1998-06-24 | 2002-12-10 | Transderm Technologies Llc | Non-invasive transdermal detection of analytes |
US6168785B1 (en) | 1998-07-16 | 2001-01-02 | Institut Pasteur | Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
DE19834070B4 (en) | 1998-07-29 | 2007-02-15 | Bruker Daltonik Gmbh | Ionization of high molecular weight substances by laser desorption from liquid matrices |
EP1329513B1 (en) | 1998-08-25 | 2011-12-07 | University of Washington | Rapid quantitative analysis of proteins or protein function in complex mixtures |
EP1107690B1 (en) | 1998-09-04 | 2003-04-16 | PowderJect Research Limited | Second medical use of a particle delivery method |
US6620123B1 (en) | 1999-12-17 | 2003-09-16 | Sontra Medical, Inc. | Method and apparatus for producing homogenous cavitation to enhance transdermal transport |
US6638727B1 (en) * | 1999-01-26 | 2003-10-28 | Cytyc Health Corporation | Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
US6702791B1 (en) | 1999-02-04 | 2004-03-09 | Integ, Inc. | Needle for body fluid tester |
US6489121B1 (en) | 1999-04-06 | 2002-12-03 | Micromass Limited | Methods of identifying peptides and proteins by mass spectrometry |
US6716636B1 (en) * | 1999-04-20 | 2004-04-06 | Target Discovery, Inc. | Methods for sequencing proteins |
US6416758B1 (en) | 1999-04-28 | 2002-07-09 | Board Of Regents, The University Of Texax System | Antibody conjugate kits for selectively inhibiting VEGF |
US6334851B1 (en) * | 1999-05-10 | 2002-01-01 | Microfab Technologies, Inc. | Method for collecting interstitial fluid from the skin |
US6642009B2 (en) | 1999-05-17 | 2003-11-04 | Cytyc Health Corporation | Isolated ductal fluid sample |
AU780752B2 (en) * | 1999-06-08 | 2005-04-14 | Nitto Denko Corporation | Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6685699B1 (en) | 1999-06-09 | 2004-02-03 | Spectrx, Inc. | Self-removing energy absorbing structure for thermal tissue ablation |
US6174287B1 (en) | 1999-06-11 | 2001-01-16 | Acuson Corporation | Medical diagnostic ultrasound system and method for continuous M-mode imaging and periodic imaging of contrast agents |
US6645465B2 (en) * | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
US20030114434A1 (en) | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
US6323186B1 (en) | 1999-09-17 | 2001-11-27 | Molecular Probes, Inc. | Phosphate-bound polyazaindacene derivatives of nucleotides |
JP2003516798A (en) * | 1999-12-16 | 2003-05-20 | アルザ・コーポレーション | Device for increasing the transdermal flow rate of extracted drugs |
AU2001241483A1 (en) | 2000-02-18 | 2001-08-27 | University Of Utah Research Foundation | Methods for extracting substances using alternating current |
GB0006141D0 (en) | 2000-03-14 | 2000-05-03 | Brax Group Ltd | Mass labels |
US6690976B2 (en) | 2000-04-13 | 2004-02-10 | Celsion Corporation | Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs |
WO2001083816A2 (en) | 2000-05-04 | 2001-11-08 | Philogen S.R.L. | Method for detecting tumors |
US6706032B2 (en) * | 2000-06-08 | 2004-03-16 | Massachusetts Institute Of Technology | Localized molecular and ionic transport to and from tissues |
WO2001093917A2 (en) * | 2000-06-08 | 2001-12-13 | Cytyc Health Corporation | Preparation for breast duct fluid collection |
US6409679B2 (en) * | 2000-06-13 | 2002-06-25 | Pacific Paragon Investment Fund Ltd. | Apparatus and method for collecting bodily fluid |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
JP3816308B2 (en) | 2000-06-19 | 2006-08-30 | ユニ・チャーム株式会社 | Disposable diapers |
CA2411102A1 (en) * | 2000-06-20 | 2001-12-27 | Idec Pharmaceutical Corporation | Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
US6589173B1 (en) | 2000-07-17 | 2003-07-08 | The Regents Of The University Of California | Ultrasound system for disease detection and patient treatment |
WO2002010745A2 (en) * | 2000-07-28 | 2002-02-07 | Cytyc Health Corporation | Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
US20020013539A1 (en) * | 2000-07-28 | 2002-01-31 | David Hung | Methods and devices for diagnosis of precancer and cancer in breast milk ducts |
DE60127965T2 (en) * | 2000-08-08 | 2007-12-20 | Cytyc Corp., Marlborough | IDENTIFICATION OF VIRAL AGENTS IN BREAST MILK CHANNELS AND ANTIVIRAL THERAPY |
IT1317108B1 (en) | 2000-12-06 | 2003-05-26 | Philogen Srl | PROCESS FOR THE SELECTION OF ANTI-ANGIOGENIC ANTI-CORPORAL FRAGMENTS, ANTI-ANGIOGENIC ANTI-CORPMENTAL FRAGMENTS SO OBTAINED AND THEIR USE. |
WO2002082051A2 (en) * | 2001-01-17 | 2002-10-17 | Tubbs Kemmons A | An integrated high throughput system for the analysis of biomolecules |
DE60221115T2 (en) | 2001-01-18 | 2008-03-13 | The Regents Of The University Of Michigan, Ann Arbor | COMPOSITIONS AND METHODS FOR USE OF FIBRONECTIN FRAGMENTS IN CANCER DIAGNOSIS |
US6756200B2 (en) | 2001-01-26 | 2004-06-29 | The Johns Hopkins University School Of Medicine | Aberrantly methylated genes as markers of breast malignancy |
US6657191B2 (en) | 2001-03-02 | 2003-12-02 | Bruker Daltonics Inc. | Means and method for multiplexing sprays in an electrospray ionization source |
US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
US7056663B2 (en) * | 2001-03-23 | 2006-06-06 | California Pacific Medical Center | Prognostic methods for breast cancer |
US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
US20030003588A1 (en) * | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
US6599891B2 (en) * | 2001-07-20 | 2003-07-29 | Qlt Inc. | Treatment of macular edema |
US6884605B2 (en) * | 2001-08-09 | 2005-04-26 | Board Of Trustees Of The University Of Arkansas | Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
WO2003020115A2 (en) | 2001-08-31 | 2003-03-13 | Amplistar Inc. | Methods and compositions for the detection of cancer |
US6630454B2 (en) * | 2001-09-10 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Method and pharmaceutical composition for the treatment of cancer |
AU2002329570A1 (en) * | 2001-10-12 | 2003-01-30 | Pfizer Products Inc. | Method of monitoring neuroprotective treatment |
WO2003040715A1 (en) | 2001-11-05 | 2003-05-15 | Irm, Llc. | Sample preparation methods for maldi mass spectrometry |
US7094549B2 (en) * | 2001-11-23 | 2006-08-22 | Syn X Pharma, Inc. | Fibronectin biopolymer marker indicative of insulin resistance |
US20030104483A1 (en) * | 2001-11-30 | 2003-06-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Liquid chromatography/fourier-transform mass spectrometry/electron capture dissociation for the analysis of proteins |
US20030186246A1 (en) | 2002-03-28 | 2003-10-02 | Willey James C. | Multiplex standardized reverse transcriptase-polymerase chain reacton method for assessment of gene expression in small biological samples |
JP4267865B2 (en) | 2002-04-19 | 2009-05-27 | 株式会社デンソー | Load drive device |
WO2004003555A1 (en) | 2002-07-01 | 2004-01-08 | University Of Rochester Medical Center | Method for determination of likelihood of occurrence of preterm labor in pregnant females |
CA2512989A1 (en) | 2003-02-06 | 2004-08-26 | Adeza Biomedical Corporation | Screening and treatment methods for prevention of preterm delivery |
CA2575675A1 (en) | 2004-07-30 | 2006-03-09 | Adeza Biomedical Corporation | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
-
2005
- 2005-07-29 CA CA002575675A patent/CA2575675A1/en not_active Abandoned
- 2005-07-29 AT AT05810341T patent/ATE534750T1/en active
- 2005-07-29 US US11/193,806 patent/US20060024724A1/en not_active Abandoned
- 2005-07-29 JP JP2007523875A patent/JP2008514900A/en not_active Withdrawn
- 2005-07-29 NZ NZ582466A patent/NZ582466A/en unknown
- 2005-07-29 EP EP05810341A patent/EP1778874B1/en active Active
- 2005-07-29 AU AU2005280528A patent/AU2005280528B2/en active Active
- 2005-07-29 EP EP10181283.2A patent/EP2299275B1/en active Active
- 2005-07-29 DK DK10181283.2T patent/DK2299275T3/en active
- 2005-07-29 WO PCT/US2005/027183 patent/WO2006026020A2/en active Application Filing
- 2005-07-29 US US11/193,561 patent/US20060024757A1/en not_active Abandoned
- 2005-07-29 US US11/193,857 patent/US20060024725A1/en not_active Abandoned
- 2005-07-29 US US11/193,771 patent/US20060024722A1/en not_active Abandoned
- 2005-07-29 US US11/193,789 patent/US7943294B2/en active Active
-
2007
- 2007-11-01 HK HK07111819.9A patent/HK1103527A1/en unknown
-
2010
- 2010-09-15 JP JP2010207039A patent/JP2011039068A/en active Pending
-
2011
- 2011-03-22 AU AU2011201303A patent/AU2011201303B2/en active Active
- 2011-04-07 US US13/081,826 patent/US8372581B2/en active Active
-
2013
- 2013-02-11 US US13/764,017 patent/US8852872B2/en active Active
-
2014
- 2014-10-06 US US14/507,079 patent/US9513298B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010585A1 (en) * | 1990-12-14 | 1992-06-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal restricted antigens |
US5693479A (en) * | 1993-03-10 | 1997-12-02 | The Trustees Of The University Of Pennsylvania | Fertility determination with transforming growth factor β |
EP1293926A2 (en) * | 1998-02-03 | 2003-03-19 | Adeza Biomedical Corporation | Start control method in a computer system |
US20030049658A1 (en) * | 1999-12-10 | 2003-03-13 | David Smart | Assay |
WO2002101075A2 (en) * | 2001-06-13 | 2002-12-19 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
WO2003036300A2 (en) * | 2001-10-26 | 2003-05-01 | University College London | Diagnosis of cervical cancer |
Non-Patent Citations (9)
Title |
---|
FEINBERG R F ET AL: "Human trophoblasts and tropho-uteronectin (TUN): A model for studying early implantation events", ASSISTED REPRODUCTION REVIEWS 1993 UNITED STATES, vol. 3, no. 1, 1993, pages 19 - 25, XP008063888, ISSN: 1051-2446 * |
IAMS JAY D ET AL: "Fetal fibronectin improves the accuracy of diagnosis of preterm labor", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 173, no. 1, 1995, pages 141 - 145, XP002379904, ISSN: 0002-9378 * |
LU GEORGE C ET AL: "Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women", OBSTETRICS AND GYNECOLOGY, vol. 97, no. 2, February 2001 (2001-02-01), pages 225 - 228, XP002379903, ISSN: 0029-7844 * |
LUTON DOMINIQUE ET AL: "Fetal fibronectin in the cervical secretion predicts accurately the onset of labor at term", EUROPEAN JOURNAL OF OBSTETRICS AND GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol. 74, no. 2, 1997, pages 161 - 164, XP002379905, ISSN: 0301-2115 * |
MOUW R J C ET AL: "High cervical fetal-fibronectin concentrations and birth within 3 days in pregnancies of 41 weeks or more", NEW ENGLAND JOURNAL OF MEDICINE 1995 UNITED STATES, vol. 332, no. 16, 1995, pages 1105, XP008063852, ISSN: 0028-4793 * |
PEACEMAN ET AL: "Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 177, no. 1, July 1997 (1997-07-01), pages 13 - 17, XP005144649, ISSN: 0002-9378 * |
TAKEUCHI K ET AL: "Localization and significance of fibronectin in peri-implantation mouse embryos.", ASIA-OCEANIA JOURNAL OF OBSTETRICS AND GYNAECOLOGY / AOFOG. JUN 1989, vol. 15, no. 2, June 1989 (1989-06-01), pages 191 - 197, XP008063893, ISSN: 0389-2328 * |
TURPEENNIEMI-HUJANEN T ET AL: "EXTRACELLULAR MATRIX INTERACTIONS IN EARLY HUMAN EMBRYOS: IMPLICATIONS FOR NORMAL IMPLANTATION EVENTS", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, US, vol. 64, no. 1, July 1995 (1995-07-01), pages 132 - 138, XP008060802, ISSN: 0015-0282 * |
WUNDERLICH H ET AL: "Fetal fibronectin: A new screening-marker for bladder cancer?", ONCOLOGY REPORTS, vol. 8, no. 3, May 2001 (2001-05-01), pages 669 - 672, XP008060794, ISSN: 1021-335X * |
Also Published As
Publication number | Publication date |
---|---|
US20060024722A1 (en) | 2006-02-02 |
US20060024757A1 (en) | 2006-02-02 |
US9513298B2 (en) | 2016-12-06 |
WO2006026020A9 (en) | 2006-07-06 |
EP2299275A2 (en) | 2011-03-23 |
AU2011201303B2 (en) | 2012-07-26 |
US20060024724A1 (en) | 2006-02-02 |
US8372581B2 (en) | 2013-02-12 |
CA2575675A1 (en) | 2006-03-09 |
US20130171672A1 (en) | 2013-07-04 |
US8852872B2 (en) | 2014-10-07 |
US20120040356A1 (en) | 2012-02-16 |
AU2011201303A1 (en) | 2011-04-07 |
DK2299275T3 (en) | 2018-05-07 |
EP2299275A3 (en) | 2011-08-03 |
AU2005280528A1 (en) | 2006-03-09 |
ATE534750T1 (en) | 2011-12-15 |
EP2299275B1 (en) | 2018-03-07 |
HK1103527A1 (en) | 2007-12-21 |
AU2005280528B2 (en) | 2010-12-23 |
US7943294B2 (en) | 2011-05-17 |
US20060024725A1 (en) | 2006-02-02 |
EP1778874A2 (en) | 2007-05-02 |
JP2008514900A (en) | 2008-05-08 |
NZ582466A (en) | 2011-09-30 |
JP2011039068A (en) | 2011-02-24 |
US20060024723A1 (en) | 2006-02-02 |
EP1778874B1 (en) | 2011-11-23 |
WO2006026020A2 (en) | 2006-03-09 |
US20150044708A1 (en) | 2015-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
WO2006126008A3 (en) | Improved immunoassay methods | |
WO2015070037A3 (en) | Polynucleotide conjugates and methods for analyte detection | |
WO2008082979A3 (en) | Diagnostic test for the detection of a molecule or drug in whole blood | |
WO2008039946A3 (en) | Integrated meter for analyzing biological samples | |
WO2006089027A3 (en) | Lateral flow test kit and method for detecting an analyte | |
WO2006014351A3 (en) | Exploring fluorophore microenvironments | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
WO2007090126A3 (en) | Compositions and methods for detecting and quantifying toxic substances in disease states | |
WO2007075928A3 (en) | Integrated patch and assay device with visual detection means | |
WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
WO2005003732A3 (en) | Diagnostic test for analytes in a sample | |
WO2006135818A3 (en) | Recirculating microfluidic device and methods of use | |
DE602005013225D1 (en) | APTAMER NANOPARTICLE CONJUGATES AND USE METHOD FOR THE DETECTION OF TARGET ANALYSTS | |
BRPI0707645B8 (en) | in vitro methods for detecting cancer in an individual and for evaluating the prognosis of an individual having, or suspected of having, ovarian cancer | |
WO2005084210A3 (en) | Multiplex detection probes | |
GB0319376D0 (en) | Histone modification detection | |
WO2007133586A3 (en) | Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets | |
WO2007056523A3 (en) | Methods for diagnosing and monitoring the progression of cancer | |
WO2008089072A3 (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
WO2008124091A3 (en) | Compositions and methods of detection | |
WO2007061940A3 (en) | Method for detecting an inflammatory disease or cancer | |
WO2006092729A3 (en) | Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals | |
WO2009086186A3 (en) | Automated method and apparatus for detecting erroneous sample collection in clinical assays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 552244 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005280528 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005810341 Country of ref document: EP Ref document number: 2575675 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007523875 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/001213 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005280528 Country of ref document: AU Date of ref document: 20050729 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005280528 Country of ref document: AU |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2005810341 Country of ref document: EP |